SevoFlo

RSS

sevoflurane

Authorised
This medicine is authorised for use in the European Union.

Overview

An overview of SevoFlo and why it is authorised in the EU.

This EPAR was last updated on 29/03/2021

Authorisation details

Product details
Name
SevoFlo
Agency product number
EMEA/V/C/000072
Active substance
sevoflurane
International non-proprietary name (INN) or common name
sevoflurane
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QN01AB08
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Revision
18
Date of issue of marketing authorisation valid throughout the European Union
11/12/2002
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

19/03/2021 SevoFlo - EMEA/V/C/000072 - IA/0024

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Anesthetics, general

Therapeutic indication

For the induction and maintenance of anaesthesia in dogs and cats.

Assessment history

How useful was this page?

Add your rating